论文信息 - Longitudinal Assessment of Circulating Tumor Mutational Burden Using a Next-Generation Sequencing Cancer Gene Panel: A Potential Biomarker of Response to Programmed Cell Death 1 (PD-1) Blockade in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma - 字舞流文

Longitudinal Assessment of Circulating Tumor Mutational Burden Using a Next-Generation Sequencing Cancer Gene Panel: A Potential Biomarker of Response to Programmed Cell Death 1 (PD-1) Blockade in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma

S. Hohaus | D. Rossi | A. Santoro | F. Ricci | C. Carlo-Stella | A. Chiti | M. Kirienko | M. Rodari | V. Spina | A. Bruscaggin | E. Rizzo | S. Locatelli | M. Magagnoli | L. Morello | G. Careddu | Eleonora Calabretta | F. Marino | F. D. Paoli | M. D. Trani | V. Cristaldi